You are here: Industry Insights > Breakthrough

News List

'Breakthrough' COVID Infections Can Still Be Deadly for Cancer Patients drugs
December 27, 2021
When fully vaccinated cancer patients develop a breakthrough case of COVID-19, most will become seriously ill and end up hospitalized, a new study finds.
The State Council's Leading Group for Deepening the Reform of the Medical and Health System Issued the Notice on Policies and Measures to Further Deepen the Reform of the Medical and Health System with Centralized Procurement & Use of Drugs as a Breakthrough chinadaily
April 13, 2020
On November 29, 2019, approved by the State Council, the Leading Group for Deepening the Reform of the Medical and Health System Issued the Notice on Several Policies and Measures to Further Deepen the Reform of the Medical and Health System with Centrali
Ridgeback Biotherapeutics Breakthrough Therapy Designation for mAb114 americanpharmaceuticalreview
September 10, 2019
Ridgeback Biotherapeutics announced the Food and Drug Administration (FDA) has recently granted mAb114, an experimental treatment for Ebola, Breakthrough Therapy designation.
Provention Bio Announces Breakthrough Therapy Designation for Teplizumab americanpharmaceuticalreview
August 07, 2019
Provention Bio announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to teplizumab (PRV-031) for the prevention or delay of clinical type 1 diabetes (T1D) in individuals at-risk of developing the disease.
FDA grants breakthrough status to new combination for melanoma pharmaceutical-technology
August 05, 2019
The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation for Nektar Therapeutics’ bempegaldesleukin (NKTR-214) in combination with Bristol-Myers Squibb (BMS)’s Opdivo (nivolumab) to treat melanoma.
Evolving World of Pharma: AI is the breakthrough disruptor we’ve been waiting for Sarah Harding
August 05, 2019
AI is impacting pharma from discovery to prescription… and beyond.
FDA Grants Breakthrough Therapy Designation for Bempegaldesleukin, Opdivo Combination americanpharmaceuticalreview
August 02, 2019
Nektar Therapeutics and Bristol-Myers Squibb announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for investigational agent bempegaldesleukin (NKTR-214) in combination with ...
Leaps by Bayer, Khloris to develop breakthrough anti-cancer vaccines biospectrumasia
April 03, 2019
Leaps by Bayer, the investment arm of the global life sciences company Bayer, and Khloris Biosciences, a biotechnology company……
Nanoparticle breakthrough in the fight against cancer worldpharmanews
January 21, 2019
A team of researchers, affiliated with UNIST has recently introduced a novel targeted drug delivery system that can improve the pharmacological and therapeutic properties of conventional cancer treatments.
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies fiercepharma
August 14, 2018
Novartis and Roche’s Xolair has seen a raft of new competitors encroach on its territory over the last few years. But now, it’s ready to carve out a new niche of its own.

Previous page 1 2 Next page